RE:RE:RE:RE:Forcing Bioasis to AnswerOh, Cresence is plan A.
I misunderstood. Along with a J&J deal that we know nothing about and a Neuramedy that was another "four bats and a bag of balls" deal, Cresence is/was "Plan A."
You do understand, poof, I'm sure, that if xB3 can make losers like the Cresence and Neuramedy stuff into winners that xB3 can also be used for:
- Brain tumours
- MS
- PD
- glioblastoma
- AD
- Neuroinflammation
- and a whole bunch of other neurodiseases that could be worth $50 billion per year.
But Neuramedy and Cresence are Plan A.
Ok.
I love how you sprinkle little gems like "catalyze" and "synergy" and "transformational" and "validation" throughout your posts.
Let me use those words in my own sentence.
Do you think that the Ellipses leak signalled that deals that would have been transformational for Bioasis and would have provided validation of the xB3 platform by leveraging the synergy between Bioasis and each of its partners would have helped to calalyze a financial and corporate renaissance for Bioasis?
I threw in "leverage" and "renaissance" because they were needed. Apologies for the vociferous pedantry.
Oh my...
jd